Although Icam1 was previously suggested to serve as a CSF biomarker for AD, we found Icam1 to be significantly upregulated (FC > 1.5) only in the hippocampus of female APP/PS1 mice and it turned out to be one of the differentially expressed fingerprint genes in this subgroup. Here, APP is linked to Alzheimer disease.